NASDAQ:ARCT
Arcturus Therapeutics Holdings Inc. Stock News
$30.41
-0.80 (-2.56%)
At Close: May 24, 2024
Stocks in Europe skid as reversal from rally continues
07:26am, Thursday, 11'th Jun 2020
European stocks slumped Thursday in early trade, losing ground for a fourth session as traders looked for a new catalyst after the breathtaking rally from...
Singapore boosting capacity for fast Covid-19 vaccine production
09:00pm, Friday, 05'th Jun 2020
Singapore is building up vaccine manufacturing capacity so production can be ramped up quickly and safely once a Covid-19 vaccine is found.. Read more at straitstimes.com.
SAN DIEGO, June 05, 2020 -- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on.
After Plummeting Over 30%, Are Arcturus Therapeutics Shares Still a Good Buy?
11:27am, Thursday, 04'th Jun 2020
Arcturus Therapeutics' (NASDAQ: ARCT) stock saw deep losses on May 27, in part because of spillover from news about patients in Moderna's (NASDAQ: MRNA) COVID-19 vaccine trial experiencing adverse re
Cramer Shares His Thoughts On UBS, Alteryx And More
12:11pm, Wednesday, 03'rd Jun 2020
On CNBC's "Mad Money Lightning Round," Jim Cramer said he's not going to recommend Ares Capital Corporation (NASDAQ: ARCC). He doesn't know what are its investments.UBS Group AG (NYSE: UBS) doesn't ha
Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine
06:11pm, Thursday, 28'th May 2020
When I first started buying ARCT shares I didn't conceive of a valuation of $1 billion, but I also didn't conceive of the global impact of a pandemic.
Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine
06:11pm, Thursday, 28'th May 2020
When I first started buying ARCT shares I didn't conceive of a valuation of $1 billion, but I also didn't conceive of the global impact of a pandemic.
Why Arcturus Therapeutics Stock Is Plunging Today
04:35pm, Wednesday, 27'th May 2020
Shares of Arcturus Therapeutics (NASDAQ: ARCT) were plunging 32.3% as of 11:43 a.m. EDT on Wednesday. Reports surfaced yesterday that one of the participants in Moderna's phase 1 study of its COVID-1
New Coronavirus Vaccine To Send Virus' Spike Protein To Activate Body's Immune Response
12:00pm, Tuesday, 26'th May 2020
Novavax is now beginning its clinical trials.
Dal Sasso, Nielsen: «Nel secondo semestre possibile chiusura in pareggio per il mercato» | Engage
04:05pm, Monday, 25'th May 2020
Secondo Dal Sasso di Nielsen, questo porterebbe il settore a chiudere il 2020 in calo a doppia cifra, in vista di un 2021 sicuramente più "effervescente"
Nielsen: pubblicità a -9,2% tra gennaio e marzo. La ripresa? Sarà nel secondo semestre | Engage
02:23pm, Monday, 25'th May 2020
Il Covid-19 ha portato il mercato pubblicitario a chiudere marzo a -29% secondo Nielsen. Ma ha anche stimolato un profondo cambiamento nella comunicazione
Ultragenyx Announces Exercise of Option to Purchase Additional Stock of Arcturus Therapeutics
12:30pm, Thursday, 21'st May 2020
Ultragenyx Pharmaceutical, Inc. (RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases and Arcturus The
The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test
12:00am, Wednesday, 20'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 19)
ADC Therapeutics SA (NYSE:...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 18)
ADC Therapeutics SA (NYSE:...
Coronavirus: Ever-changing profile of a silent killer with many questions left unanswered
09:00pm, Wednesday, 13'th May 2020
Why is this virus so much more contagious than Sars? Why do some patients develop a severe form of the disease while others do not?. Read more at straitstimes.com.
